Acute neuromuscular failure related to long-term botulinum toxin therapy.
Coletti Moja
Mario
M
Department of Neurology, S. Croce Hospital, Cuneo, Italy. neurologia@sanluigi.piemonte.it
Dimanico
Ugo
U
Mongini
Tiziana
T
Cavaciocchi
Valentina
V
Gerbino Promis
Pier Carlo
PC
Grasso
Enzo
E
D000208:Acute Disease; D000328:Adult; D001706:Biopsy; D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects / Q000473:pathology; D009465:Neuromuscular Agents / Q000009:adverse effects*; D009468:Neuromuscular Diseases / Q000139:chemically induced*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011782:Quadriplegia / Q000188:drug therapy; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; D011729:Pyridostigmine Bromide